Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Central Nervous System Disease is Scopus-indexed (Q2, CiteScore 4.8), WoS ESCI, DOAJ. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 1179-5735Verify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 141 / 403 | 65th | Q2 |
| Neurology | 78 / 201 | 61st | Q2 |
| Cellular and Molecular Neuroscience | 64 / 102 | 37th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q2, CiteScore 4.8.
Journal of Central Nervous System Disease is Q2 in Neurology (clinical) (rank 141 of 403), Q2 in Neurology (rank 78 of 201) and Q3 in Cellular and Molecular Neuroscience (rank 64 of 102), by CiteScore 2025.
Journal of Central Nervous System Disease is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.8, which places it in quartile Q2 at the 65th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.719, quartile Q2, with an H-index of 18.
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Central Nervous System Disease is published by SAGE Publications Inc. Its ISSN is 1179-5735.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Central Nervous System Disease has an h-index of 34 and a 2-year mean of 2.65 citations per paper (OpenAlex). Its Scopus CiteScore is 4.8, quartile Q2. On 2-year citations it ranks #100 of 403 Scopus journals in Neurology (clinical).
Journal of Central Nervous System Disease published 29 papers in 2025; its busiest recent year was 2022 with 42. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2023–2026), authors are most often from China (26.8%), United States (21.6%) and Germany (8.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.